Introduction
To clarify the pathophysiology of essential hypertension in the elderly as well as to improve management of the disease, we studied the reninangiotensin-aldosterone system in individuals with and without hypertension using an angiotensin I1 antagonist, [Sar1, 11e81angiotensin 11 ([Sar1, .
Materials and methods
Twenty-two individuals 60 years old or older were studied. Twelve had hypertension (six men and six women, age 74 f 3 years (mean f SEM) and 10 were normotensive (five men and five women, age 75 f 3 years). Ten patients kss than 60 years old with hypertension were also studied (five men and five women, age 42 f 2 years). All hypertensive patients had blood pressures greater than 160 mmHg systolic and/or 90 mmHg diastolic after lying supine for 2 min. Patients with secondary hypertension or severe cardiovascular complications were excluded.
Antihypertensive medications were discontinued at least 2 weeks before the study. Diets were unrestricted. The subjects were kept supine during the test. [Sar1,11e81ANGII (Dai-ichi Pharmaceutical Co. Ltd, Tokyo) was infused at a rate of 600 ng min-I kg-l for 30 min 1 h after intravenous injection of 40 mg of frusemide (Ogihara, Hata, Maruyama, Mikami, Nakamaru, Okada & Kumahara, 1978) . Infusion of [Sar', Ile81ANGII at a rate of 600 ng min-I kg-I causes no appreciable change in mean blood pressure (the sum of the diastolic and one-third of the pulse pressure) in frusemide-treated normal subjects (Yamamoto, Doi, Ogihara, Ichihara, Hata & Kumahara, 1976) , whereas in patients with angiotensinogenic hypertension there is a decrease in mean blood pressure of more than 10 mmHg (Ogihara, Hata, Mikami, Nakamaru, Mandai & Kumahara, 1976) . Blood pressure was monitored before and during the infusion with an automated device (Non-stetho, Parama Ltd, Tokyo). The mean of five readings before the infusion of [Sarl,Ile*]ANGII was used for the control blood pressure. The blood pressure during the infusion was expressed as the mean of the blood pressures 10, 20 and 30 min after beginning the infusion. The change in the mean blood pressure was calculated as the difference between the control blood pressure and that during the infusion.
Blood was drawn from each subject just before the infusion of [Sar1,11e81ANG11 for assay of plasma renin activity and plasma aldosterone concentration ([aldosteronel). Blood samples were drawn in cold vacuum tubes containing disodium EDTA to provide 1 mg/ml. Plasma renin activity and [aldosteronel were measured by radioimmunoassays with commercial kits (Ogihara, Yamamoto, Doi, Omori & Kumahara, 1973;  Ogihara, Iinuma, Nishi, Arakawa, Takagi, Kurata, Miyai & Kumahara, 1977). Statistical significance was assessed by the analysis of variance, correlation coefficients and Student's t-test (Siegel, 1956 ).
The Ethical Committee of the Department of Medicine and Geriatrics approved the protocol and informed consent was obtained from each subject after full explanation.
Results
Blood pressure rose significantly higher during the infusion of [Sar', Ile81ANGII in the elderly normotensive and hypertensive patients than it did in the middle-aged hypertensive patients (P < 0.01) (Fig. 1) .
Plasma renin activity and [aldosteronel were markedly suppressed in the elderly, compared with the middle-aged hypertensive patients: mean plasma renin activity, 0.9 f 0.3 vs 4.4 f 0.6 ng h-' ml-I (P < 0.01); mean [aldosteronel, 38 f 6 vs 112 k 6 pg/ml (P < 0.01). The two values were similar (P > 0.1) in the elderly with and without hypertension.
Large correlation coefficients were observed between age, plasma renin activity, [aldosteronel and the change in mean blood pressure (A mean B.P.) with [Sar1,11e8]ANGII infusion: age vs plasma renin activity -0.85, age vs A mean B.P. Vetter, 1977) . Our data agree with these earlier reports. The pressor responses observed in our elderly hypertensive patients and normotensive subjects may be due to their hyporeninaemia. These results indicate that the renin-angiotensin-aldosterone system in elderly patients with essential hypertension does not differ from that in the non-hypertensive elderly subjects and is presumably not responsible for elevation of their blood pressure.
